Scharioth Macula Lens - Meeting/2017/DISTRIBUTORs... · PDF file• Who are...
date post
27-Jul-2018Category
Documents
view
215download
0
Embed Size (px)
Transcript of Scharioth Macula Lens - Meeting/2017/DISTRIBUTORs... · PDF file• Who are...
SCHARIOTH MACULA LENSThe Magnifier in The Eye The New Hope for Patients with Dry AMD
Introduction - Age-Related Macular Degeneration
Age-related macular degeneration (AMD) affects mostly the elderly and causes vision loss in the center of the visual field, significantly decreasing patients quality of life.
Types of AMD:Healthy visionVision with AMD
Neovascular or wet AMDAbnormal blood vessels appear in macula
Dry AMDYellow deposits (drusen) in macula
Source dimages: http://www.areds2.org.uk
http://www.areds2.org.uk/
Introduction - Age-Related Macular Degeneration
AMD is the leading cause of blindness in developed countries
Almost 30M people suffer from AMD worldwide, 90% of them in the dry form
Introduction - Age-Related Macular Degeneration
HUGE MARKET
Treatment Options
Currently pharmaceutical treatment is available for wet AMD only.
Options for patients suffering from dry AMD have been limited to
Low vision aids: hand-held magnifiers, monoculars, loupes, electronic devices (video magnifiers)
Surgery: Low vision magnifying intraocular implants (e.g. Lipshitz mini telescope).
Sources dimages: http://www.drballitch.com, http://visionaid.co.uk
http://www.drballitch.com/http://visionaid.co.uk/
The New Hope The Scharioth Macula Lens
Easy and safe surgery
Small incision
No visual field reduction
Unaffected distance vision
Independent from lens status
Reversible
Affordable
Goals for developing a novel solution:The Scharioth Macula Lens
A45SML/A45SMYfrom Medicontur
Developed by Prof. Gabor B. Scharioth
SML Features
Central 1.5 mm diameter zone with +10.0D addition
Peripheral zone optically neutral
Bifocal design:
SML Features
Round polished edges no chafing
effect
8 1
Implantation site: ciliary sulcus
2
4 flex haptics for perfect fit
3
Non-torque design rotational stability
4
Square design no iris capture
7
Easy and safe surgery through 2.2 mm incision
6
Hydrophilic material with very low chromatic
aberration
5
Convex-concave optic no IOL touch
SML is safe
Proofs:
implanted more than 3.000 patented Add-On platform
In vitro evaluation of the lens
SML Mode of Action
Near vision:Pupil is constricted (near vision miosis) light rays pass through the central region of the SML, providing a magnified image on the macula. Due to high dioptric power of the central region, sharp vision is achieved at a distance of about 15 cm (d).
Distance vision:Pupil is dilated when focusing on a distant object light rays passing through the peripheral region of the SML will dominate over those passing through the central region (dashed lines).
SML Mode of Action
SML Mode of Action
JCRS 2005, 31, 1618
SML Mode of Action
By magnifying the image twofold, SML directs light rays to the rest of the damaged foveal region, thus enabling the patient to read, write, and resume hobbies they had to stop due to vision problems.
Without SML With SML*
* ANIMATION: Magnifying the image twofold
SML Implantation
Implantation is done following cataract surgery but
implantations may be performed simultaneously if
necessary
Monocular implantation in the better-seeing eye
Easy implantation using a standard IOL injector through a
2.2 mm incision
No extensive training is required no learning curve
SML Clinical Evidence
Prospective study; follow up 6 months
8 patients/8 eyes
Distance VA was NOT AFFECTED
NVA improved in 7 eyes
One patient out of 7 did not have any
improvement of NVA due to very low BCDVA before
surgery (0.05 ETDRS)
Most patients were able to read newspaper
There were not any complications related to
surgery or to the implant occurring during
follow up period
Overall satisfied patients
Scharioth GB: New add-on intraocular lens for patients with age related macular degeneration. JCRS;41:1559-1563
SML Clinical Evidence
SML Indications
Who have dry AMD and have near vision difficulties
Who suffer from other retinal conditions (diabetic retinopathy, myopic
retinopathy, hereditary retinal diseases)
Whose distance vision is better than 0.05 (ETDRS, decimal)
Who are motivated
Who are pseudophakic or are candidates for cataract surgery
The Scharioth Macula Lens is recommended for patients
SML Contraindications
Wet AMD (active/exudative stage)
Zonulopathy
Subluxation
Progressive glaucoma
Active iris neovascularization
Shallow ACD (
SML in Use
Better quality of life Happy patient
Patient with vision aid Patient with SML
HOW TO CHOSE A PROPER PATIENT?
KEY: MOTIVATION & COMMUNICATION WITH THE PATIENT
implanted should be better seeing eye of the patient
Pseudophakic patients and with dry form AMD or maculopathy or inactive neovascular AMD/othre maculopythy interval between cataract surgery and the SML implantation has to be equal or bigger than 1 months In case of clear lens crystalline in some cases might be both surgeries performed in one session
BCDVA equal or less than 0.32 and equal or more than 0.1 (decimal ETDRS charts)
Preoperative NVA acuity will be examined as follows: Patients will read from distance about 40 cm with the addition of +2.5 dpt(examination A) and from distance about 15 cm with the addition of +6 dpt (examination B). Only if there will be an improvement; the best 3 or more lines with the examination B compare to examination A; BUT if 1 or 2 lines improved and patients is happy with it the SML is indicated
IMPORTANT: based on below explained test, we can PREDICT patient NVA after the SML implantation important for communication and for patients understanding about the probable vision after surgery
EXCLUSION CRITERIA:
Active neovascular AMD/maculopathy
BCDVA worse than 0.1 or better than 0.32 (ETDRS charts; decimal)
iris neovascularisation
severe zonulopathy
ACD < 2.8 mm (from endotel)
Narrow angle, i.e., < Schaefer grade 2
Status post complicated eye surgery
congenital eye abnormality
advanced glaucoma with significant visual field defects
pigment dispersion syndrome
uveitis
long-term anti-inflammatory treatment
retinal detachment
corneal diseases involving the central cornea
inadequate visualization of the fundus on preoperative examination
patients deemed by the clinical investigator because of any systemic disease.
Pupilary abnormalities; photopic pupil less than 2.5 mm
no-go criteria :
unexpected surgical complication
SML CompetitorsMarket overview
Telescopic solution
IOL-VIP
IOL-Revolution
IOL-Foldable
IOL-K
9G-X2
Lipshitz telescope
The SchariothMacula Lens
Real Competitors
iolAMD
iolAMD EyeMax
IOL-VIP
2007
2010
Lipshitztelescope
IOL-VIP Revolution
2012
2014
iolAMD
SchariothMacula
Lens
2015
2016
iolAMDEyeMaxMono
IOL-VIP - 2007
Material PMMA with UV filter
Optic2 IOLs
Bag: 5.0 mm, 7, C-loops, -64 D, biconcaveAnterior chamber: 5.0 mm, 10, Z-shape, +55 D, biconvex
Incision size 8.0 mm
How it works Galilean telescope magnification and deviation of image
Magnification 1.3x, prismatic effect 10 D, monocular
Adaptation time 12 weeks rehabilitation
Advantages Improved vision
Disadvantages
Surgery 45 min; large incision sizeSutures needed
Reduced field of viewLong term rehabilitation
IOL-VIP Studies
1 Clinical magnification and residual refraction after implantation of a double intraocular lens system in patients with macular degeneration.
Amselem L1, Diaz-Llopis M, Felipe A, Artigas JM, Navea A, Garca-Delpech S.J Cataract Refract Surg. 2008 Sep;34(9):1571-7. doi: 10.1016/j.jcrs.2008.05.032.PMID: 18721722
Hospital General Universitario, Spain
13 eyes of 10 patients
Prospective study
1 year follow-up
2 The IOL-Vip System: a double intraocular lens implant for visual rehabilitation of patients with macular disease.
Orzalesi N1, Pierrottet CO, Zenoni S, Savaresi C.Ophthalmology. 2007 May;114(5):860-5.PMID: 17467525
Italy
40 eyes of 35 patients
Pilot study
Mean follow-up 20 months
IOL-VIP Revolution - 2012
Material PMMA with UV filter
Optic2 IOLs in the bag
5.0 mm, 15, 0.0 - -100.0 D, biconcave5.0 mm, 10,0.0 - +100.0 D, biconvex within a silicone gutter
Incision size 8.0 mm
How it works Galilean telescope magnification and deviation of image
Magnification -
Adaptation time 12 weeks rehabilitation
Advantages Easily rotated
Disadvantages
Surgery 60 min, large incisionSutures needed
Complex surgical procedure Reduced visual field
Long term rehabilitationLack of scientific evidence /studies
IOL-VIP Foldable
Material Acrylic with UV filter
Optic2 IOLs
Bag: 5.0 mm, 0.0 - -100.0 D Sulcus: 5.0 mm, 0.0 - +100.0 D
Incision size 8.0 mm
How it works Galilean telescope magnificatio